BEALS, Channing Rodney,JONES, Todd, K.,GRIMM, Kurt G.,BLANKMAN, Jacqueline Lorayne,GRICE, Cheryl A
申请号：
CR20190242
公开号：
CR20190242A
申请日:
2017.11.15
申请国别(地区):
CR
年份:
2019
代理人:
摘要：
MAGL inhibitors are described here. 4-(2-(Pirrolidin-1-il) -4-(sulfur trifluoride) benzo-1-carbohydrate-1,1,3,3,3-hexafluoropropane-2-International Labour Organization, including various crystalline forms, salts and acceptable pharmaceutical solutions, are ecstasy inhibitors 1,1,3,3-hexafluoropropane-2-yl-4-(2-(Pyrolidin-1-yl) -4-(sulfur trifluoride) benzo. Including crystalline forms and pharmaceutically acceptable salts and solvates.Aquí se describe el inhibidor de MAGL. 4-(2-(pirrolidin-1-il)-4-(trifluorometil)bencil)piperazin-1-carboxilato de1,1,1,3,3,3-hexafluoropropan-2-ilo, incluyendo formas cristalinas y sales y solvatos farmacéuticamente aceptables del mismoDescribed herein is the MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts and solvates thereof.
